Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Exciting developments in Germany regarding legalization of cannabis
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Market Notices: Market Notice 174/22 – Information regarding the rights issue from DanCann Pharma A/S
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S brings forward the release of the quarterly report for Q3 2022
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Minutes of annual general meeting